Wanbury

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE107F01022
  • NSEID: WANBURY
  • BSEID: 524212
INR
238.05
-6.55 (-2.68%)
BSENSE

Dec 05

BSE+NSE Vol: 21.44 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Net Sales
599.51
575.65
499.65
511.19
392.52
367.45
391.37
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
599.51
575.65
499.65
511.19
392.52
367.45
391.37
Raw Material Cost
277.88
289.22
257.48
304.93
213.70
146.42
164.99
Purchase of Finished goods
15.08
17.30
15.98
20.14
10.65
23.33
36.27
(Increase) / Decrease In Stocks
1.51
-3.89
29.13
-24.79
-7.20
5.99
-5.06
Employee Cost
104.24
86.92
81.00
74.81
64.15
67.48
75.89
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.01
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
124.49
116.10
92.89
100.77
93.20
100.79
103.74
Total Expenditure (Excl Depreciation)
523.20
505.65
476.48
475.87
374.50
344.01
375.83
Operating Profit (PBDIT) excl Other Income
76.31
70.00
23.17
35.32
18.02
23.44
15.54
Other Income
3.49
2.99
0.91
1.51
2.40
1.14
9.33
Operating Profit (PBDIT)
79.80
72.99
24.08
36.83
20.42
24.58
24.87
Interest
36.95
29.18
21.39
20.61
23.07
32.87
39.88
Exceptional Items
0.00
25.56
-0.59
76.37
0.00
82.64
0.00
Gross Profit (PBDT)
42.85
69.37
2.10
92.59
-2.65
74.35
-15.01
Depreciation
13.31
13.03
12.38
11.45
9.75
9.68
9.97
Profit Before Tax
29.55
56.34
-10.29
81.13
-12.41
64.67
-24.98
Tax
-0.98
0.38
0.11
-0.35
0.20
0.21
-0.14
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
30.53
55.96
-10.40
81.47
-12.61
64.46
-24.85
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
30.53
55.96
-10.40
81.47
-12.61
64.46
-24.85
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
30.53
55.96
-10.40
81.47
-12.61
64.46
-24.85
Equity Capital
32.77
32.75
32.71
32.67
25.02
25.00
23.72
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
26.50
-4.80
-65.52
-56.09
-161.26
-168.45
-233.00
Earnings per share (EPS)
9.32
17.09
-3.18
24.94
-5.04
25.78
-10.48
Diluted Earnings per share
8.98
16.89
-3.18
25.21
-5.04
26.9
-10.48
Operating Profit Margin (Excl OI)
12.73%
12.16%
4.64%
6.91%
4.59%
6.38%
3.97%
Gross Profit Margin
7.15%
12.05%
0.42%
18.11%
-0.68%
20.23%
-3.84%
PAT Margin
5.09%
9.72%
-2.08%
15.94%
-3.21%
17.54%
-6.35%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 4.14% vs 15.21% in Mar 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Mar 2025 is -45.44% vs 638.08% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 9.01% vs 202.11% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 26.63% vs 36.42% in Mar 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2025 has improved from Mar 2024

Compare Annual Results Of Wanbury With
Markets Mojo
Figures in Cr
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
599.51
177.58
421.93
237.60%
Other Operating Income
0.00
0.00
0.00
Total Operating income
599.51
177.58
421.93
237.60%
Raw Material Cost
277.88
95.47
182.41
191.07%
Purchase of Finished goods
15.08
0.00
15.08
(Increase) / Decrease In Stocks
1.51
-13.20
14.71
111.44%
Employee Cost
104.24
31.65
72.59
229.35%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
-0.01
0.01
100.00%
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
124.49
13.99
110.50
789.85%
Total Expenditure (Excl Depreciation)
523.20
127.90
395.30
309.07%
Operating Profit (PBDIT) excl Other Income
76.31
49.68
26.63
53.60%
Other Income
3.49
1.31
2.18
166.41%
Operating Profit (PBDIT)
79.80
50.99
28.81
56.50%
Interest
36.95
8.54
28.41
332.67%
Exceptional Items
0.00
-0.05
0.05
100.00%
Gross Profit (PBDT)
42.85
42.40
0.45
1.06%
Depreciation
13.31
20.88
-7.57
-36.25%
Profit Before Tax
29.55
21.53
8.02
37.25%
Tax
-0.98
4.03
-5.01
-124.32%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
30.53
17.50
13.03
74.46%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
30.53
17.50
13.03
74.46%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
30.53
17.50
13.03
74.46%
Equity Capital
32.77
21.95
10.82
49.29%
Face Value
10.00
10.00
0.00
Reserves
26.50
260.65
-234.15
-89.83%
Earnings per share (EPS)
9.32
7.97
1.35
16.94%
Diluted Earnings per share
8.98
7.95
1.03
12.96%
Operating Profit Margin (Excl OI)
12.73%
27.98%
0.00
-15.25%
Gross Profit Margin
7.15%
23.88%
0.00
-16.73%
PAT Margin
5.09%
9.85%
0.00
-4.76%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 599.51 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 4.14% vs 15.21% in Mar 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 30.53 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -45.44% vs 638.08% in Mar 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 76.31 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 9.01% vs 202.11% in Mar 2024

Annual - Interest
Interest 36.95 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 26.63% vs 36.42% in Mar 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 12.73%
in Mar 2025

Figures in %
stock-summary

YoY Growth in year ended Mar 2025 has improved from Mar 2024